CRISPR Therapeutics, the biotech firm founded by CRISPR researcher Emmanuelle Charpentier, now at the Max Planck Institute for Infection Biology, is submitting paperwork in Europe and the US to embark on clinical trials, Wired reports.
To read the full story....
Already have a GenomeWeb or 360Dx account?
.